Allstate’s Deep-Value Edge Tops Progressive in Q1 2026
Allstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
This guide demonstrates how to leverage historical returns to shape retirement-index-fund allocations and risk management.
21,926 articlesAllstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Warren Buffett publicly stated he initiated Berkshire Hathaway’s larger stake in Alphabet, signaling a top-down push ...
A market correction tied to margin unwind can create a rare, patient-investor entry point. This article explains how ...
CFOs are increasingly moving into the CEO chair, but AI-driven disruption is testing how long they can stay. New data...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
As XPEL gears up for 2025 earnings insights, investors need a clear view of growth drivers, margin discipline, and po...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
A few well-timed picks can dramatically change a portfolio. This guide breaks down what to look for and presents thre...
Walmart has built a durable model, but three looming risks could erode its long-term edge. This guide breaks down tho...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...